Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported Operating Income Loss of -$54.15 million for the year ending 2025.
- TREACE MEDICAL CONCEPTS, INC. showed an increase of +2.8% in Operating Income Loss from 2024 to 2025.
- This data is from TREACE MEDICAL CONCEPTS, INC.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2019 to 2025), TREACE MEDICAL CONCEPTS, INC.'s Operating Income Loss has declined by 1,431.9%.
- Historical annual values: Fiscal year 2025: -$54.15 million | Fiscal year 2024: -$55.69 million | Fiscal year 2023: -$51.43 million | Fiscal year 2022: -$34.84 million | Fiscal year 2021: -$16.51 million | Fiscal year 2020: $855.0 thousand | Fiscal year 2019: -$3.54 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: